MacroGenics
MGNX
#8441
Rank
$0.26 B
Marketcap
$4.13
Share price
4.29%
Change (1 day)
212.88%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of September 2025 : $67 Million USD

According to MacroGenics's latest financial reports the company has $67 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$0.11 B-23.95%
2023-12-31$$0.15 B7.46%
2022-12-31$$0.14 B-40.73%
2021-12-31$$0.23 B-19.02%
2020-12-31$$0.29 B28.29%
2019-12-31$$0.23 B-5.04%
2018-12-31$$0.24 B-18.83%
2017-12-31$$0.29 B11.34%
2016-12-31$$0.26 B-14.23%
2015-12-31$$0.31 B158.35%
2014-12-31$$0.12 B53.69%
2013-12-31$$78.91 M-1058.01%
2012-12-31$-$8.24 Million-52.89%
2011-12-31$-$17.49 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$90.40 B 134,829.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.19 B 46,463.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.19 B 13,616.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$23.43 B 34,871.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$45.93 B 68,452.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$20.10 B 29,902.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.63 B 848.62%๐Ÿ‡บ๐Ÿ‡ธ USA